Company Filing History:
Years Active: 2001
Title: Susan Adrienne Morgan: Innovator in Humanized Antibodies
Introduction
Susan Adrienne Morgan is a prominent inventor based in Slough, GB. She has made significant contributions to the field of biotechnology, particularly in the development of humanized antibodies. Her work has implications for various medical applications, showcasing her expertise and dedication to innovation.
Latest Patents
Susan holds a patent for humanized antibodies, which specifically target the epitope recognized by the murine monoclonal antibody L243. This invention not only describes the antibodies themselves but also outlines the processes for their preparation, as well as their pharmaceutical compositions and medical uses. This patent highlights her innovative approach to addressing medical challenges through advanced biotechnological solutions.
Career Highlights
Throughout her career, Susan has been associated with Celltech Therapeutics Limited, where she has played a crucial role in advancing therapeutic technologies. Her work has been instrumental in the development of new treatments that leverage the power of humanized antibodies.
Collaborations
Susan has collaborated with notable colleagues in her field, including John Spencer Emtage and Mark William Bodmer. These partnerships have fostered a collaborative environment that enhances the research and development of innovative biotechnological solutions.
Conclusion
Susan Adrienne Morgan's contributions to the field of humanized antibodies exemplify her commitment to innovation and medical advancement. Her work continues to influence the biotechnology landscape, paving the way for future breakthroughs in therapeutic applications.